|
TBK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.620390E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.207400E-01 |
| Normal-vs-Stage2 |
2.329600E-02 |
| Normal-vs-Stage3 |
1.219230E-01 |
| Normal-vs-Stage4 |
7.891800E-02 |
| Stage1-vs-Stage2 |
5.911500E-02 |
| Stage1-vs-Stage3 |
2.389600E-01 |
| Stage1-vs-Stage4 |
1.942770E-01 |
| Stage2-vs-Stage3 |
3.303600E-01 |
| Stage2-vs-Stage4 |
5.730000E-01 |
| Stage3-vs-Stage4 |
7.013200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.897650E-01 |
| Normal-vs-AfricanAmerican |
9.257000E-01 |
| Normal-vs-Asian |
8.136800E-01 |
| Caucasian-vs-AfricanAmerican |
5.174800E-01 |
| Caucasian-vs-Asian |
2.202200E-01 |
| AfricanAmerican-vs-Asian |
7.999000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.820200E-01 |
| Normal-vs-Female |
2.134600E-01 |
| Male-vs-Female |
6.616000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.102600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.619400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.899800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.147040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.805050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.824400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.430400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.222400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.012800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.285600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.196400E-01 |
| Classical-VS-Follicular |
9.171800E-04 |
| Classical-VS-Other |
3.433200E-01 |
| Classical-VS-Normal |
9.380800E-01 |
| Tall-VS-Follicular |
6.916400E-02 |
| Tall-VS-Other |
5.493800E-01 |
| Tall-VS-Normal |
5.099800E-01 |
| Follicular-VS-Other |
7.262200E-01 |
| Follicular-VS-Normal |
5.003700E-03 |
| Other-VS-Normal |
2.958600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.317000E-03 |
| Normal-vs-N1 |
1.943400E-01 |
| N0-vs-N1 |
4.464400E-01 |
|
|
